MedPharm’s new facility for process development and small-scale manufacturing is in North Carolina, near its existing R&D center.
MedPharm is opening a new location in Raleigh-Durham, NC, that will expand its contract development and manufacturing organization services in topical and transdermal delivery. The new facility will double the company’s existing footprint and will support process development and clinical and small-scale commercial manufacturing for semi-solid and liquid pharmaceutical products. The new site is located near MedPharm’s current Center of Excellence for topical and transdermal development and adds US good manufacturing practice (GMP) manufacturing.
“MedPharm’s investment in this facility is a clear demonstration of our continued commitment to a global vision by expanding client services downstream into commercial manufacturing,” said Eugene Ciolfi, MedPharm’s president and CEO, in the June 2, 2021 press release.
Source: MedPharm
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.